Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial
Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page
- Check7 days agoChange DetectedAdded Gurgaon, India, 122001 as a location and removed Gūrgaon, India, 122001 as a location.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2, a minor label change with no impact on page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedThe India location entry was updated from Gurgaon, India, 122001 to Gūrgaon, India, 122001.SummaryDifference0.0%

- Check43 days agoChange DetectedThe changes consist of updated metadata timestamps (2026-01-21, 2026-01-20, 2026-01) and a new 'Last Update Posted' entry. The core study content, including eligibility, cohorts, and endpoints, remains unchanged.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4. There are no visible changes to the study content, layout, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check72 days agoChange DetectedNew locations across the US states, Canadian provinces, and Gurgaon, India were added, and several existing sites were removed.SummaryDifference0.9%

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.